Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 07:58 am Sale |
2024-09-30 | 13G | Kronos Bio, Inc. KRON |
Omega Fund V L.P. | 0 0.000% |
-3,838,883 (Position Closed) |
Filing History |
| 2024-10-18 4:15 pm Sale |
2024-09-04 | 13D | Nuvation Bio Inc. NUVB |
Omega Fund V L.P. | 13,072,340 3.900% |
-2,000,000 (-13.27%) |
Filing History |
| 2023-02-13 4:47 pm Purchase |
2022-12-31 | 13G | Kronos Bio, Inc. KRON |
Omega Fund V L.P. | 3,838,883 6.740% |
20,600 (+0.54%) |
Filing History |
| 2023-02-13 4:40 pm Sale |
2022-04-05 | 13D | Nuvation Bio Inc. NUVB |
Omega Fund V L.P. | 15,072,340 6.900% |
-13,140,036 (-46.58%) |
Filing History |
| 2022-02-14 4:56 pm Sale |
2021-12-31 | 13G | Morphic Holding, Inc. MORF |
Omega Fund V L.P. | 1,200,014 3.300% |
-1,732,257 (-59.08%) |
Filing History |
| 2022-02-14 4:48 pm Sale |
2021-12-31 | 13G | Cidara Therapeutics, Inc. CDTX |
Omega Fund V L.P. | 62,500 1.800% |
-100,262 (-61.60%) |
Filing History |
| 2021-02-19 4:18 pm Purchase |
2021-02-10 | 13D | Nuvation Bio Inc. NUVB |
Omega Fund V L.P. | 28,212,376 13.000% |
28,212,376 (New Position) |
Filing History |
| 2021-02-12 2:23 pm Sale |
2020-12-31 | 13G | Morphic Holding, Inc. MORF |
Omega Fund V L.P. | 2,932,271 9.400% |
-37,311 (-1.26%) |
Filing History |
| 2021-02-12 1:51 pm Purchase |
2020-12-31 | 13G | Cidara Therapeutics, Inc. CDTX |
Omega Fund V L.P. | 162,762 7.200% |
18,237 (+12.62%) |
Filing History |
| 2021-02-12 1:22 pm Purchase |
2020-12-31 | 13G | Kronos Bio, Inc. KRON |
Omega Fund V L.P. | 3,818,283 6.800% |
3,818,283 (New Position) |
Filing History |
| 2021-02-12 12:59 pm Sale |
2020-12-31 | 13G | Gossamer Bio, Inc. GOSS |
Omega Fund V L.P. | 3,320,608 4.400% |
-2,798,737 (-45.74%) |
Filing History |